Product Details for: Riabni

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/10ML (10MG/ML)
Single-Dose Vial
351(k) Biosimilar
Riabni
Rx
002
Injection
Intravenous
500MG/50ML (10MG/ML)
Single-Dose Vial
351(k) Biosimilar
Riabni
Rx
Proper Name
rituximab-arrx
Reference Product Proper Name
rituximab
Reference Product Properietary Name
Rituxan
BLA Number
761140
Applicant
Amgen Inc.
Original Approval Date
December 17, 2020
Date of First Licensure
RETURN TO SEARCH RESULTS